AUTL AUTOLUS THERAPEUTICS PLC

Ownership history in Syncona Portfolio Ltd  ·  17 quarters on record

This page tracks every 13F SEC filing in which Syncona Portfolio Ltd reported a position in AUTOLUS THERAPEUTICS PLC (AUTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
98.24% (2025 Q2)
Avg. % of fund
71.8%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 16,640,720 0% 96.48% $33.12B $1.99
2025 Q3 UNCHANGED 16,640,720 0% 97.82% $27.12B $1.63
2025 Q2 UNCHANGED 16,640,720 0% 98.24% $37.94B $2.28
2025 Q1 UNCHANGED 16,640,720 0% 97.81% $25.79B $1.55
2024 Q4 REDUCED 16,640,720 -1,913,904 -10.3% 73.83% $39.11B $2.35
2024 Q3 REDUCED 18,554,624 -2,792,205 -13.1% 83.42% $67.35B $3.63
2024 Q2 UNCHANGED 21,346,829 0% 86.51% $74.29B $3.48
2024 Q1 UNCHANGED 21,346,829 0% 90.76% $136.2M $6.38
2023 Q4 UNCHANGED 21,346,829 0% 87.15% $137.5M $6.44
2023 Q3 UNCHANGED 21,346,829 0% 74.11% $49.74B $2.33
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AUTL price (monthly, adj. close)
← Back to Syncona Portfolio Ltd Holdings